The term "brain tumor" refers to a collection of neoplasms,each with its own biology, prognosis, and treatment; these tumorsare better identified as "intracranial neoplasms," since somedo not arise from brain tissue (e.g., meningiomas and lymphomas)(Table 1). However, for most intracranial tumors, the clinicalpresentation, diagnostic approach, and initial treatment aresimilar. This article will focus on general presentation, diagnosis,and specific treatment.
View this table: [in this window]
[in a new window]
Table 1. Histologic Classification of Tumors of the Central Nervous System.
Epidemiology
The American Cancer Society estimates that 16,800 new intracranialtumors were diagnosed in 1999, more than double the number ofdiagnosed cases of . . . [Full Text of this Article]
Clinical Presentation
Diagnosis
Glial Tumors
Astrocytic Tumors
Astrocytoma
Malignant Astrocytoma
Oligodendroglial Tumors
Low-Grade Oligodendroglioma
Anaplastic Oligodendroglioma
Meningioma
Primary Central Nervous System Lymphoma
Conclusions
Source Information
From the Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York.
Address reprint requests to Dr. DeAngelis at the Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, or at deangell@mskcc.org.
References
This article has been cited by other articles:
Brown, P. D., Krishnan, S., Sarkaria, J. N., Wu, W., Jaeckle, K. A., Uhm, J. H., Geoffroy, F. J., Arusell, R., Kitange, G., Jenkins, R. B., Kugler, J. W., Morton, R. F., Rowland, K. M. Jr, Mischel, P., Yong, W. H., Scheithauer, B. W., Schiff, D., Giannini, C., Buckner, J. C.
(2008). Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177. JCO
26: 5603-5609
[Abstract][Full Text]
Desjardins, A., Reardon, D. A., Herndon, J. E. II, Marcello, J., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., Bailey, L., Bigner, D. D., Friedman, A. H., Friedman, H. S., Vredenburgh, J. J.
(2008). Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas. Clin. Cancer Res.
14: 7068-7073
[Abstract][Full Text]
Kostianovsky, A. M., Maier, L. M., Anderson, R. C., Bruce, J. N., Anderson, D. E.
(2008). Astrocytic Regulation of Human Monocytic/Microglial Activation. J. Immunol.
181: 5425-5432
[Abstract][Full Text]
Opel, D., Westhoff, M.-A., Bender, A., Braun, V., Debatin, K.-M., Fulda, S.
(2008). Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- and Drug-Induced Apoptosis. Cancer Res.
68: 6271-6280
[Abstract][Full Text]
Mason, W. P., Cairncross, J. G.
(2008). Invited Article: The expanding impact of molecular biology on the diagnosis and treatment of gliomas. Neurology
71: 365-373
[Abstract][Full Text]
Wheeler, C. J., Black, K. L., Liu, G., Mazer, M., Zhang, X.-x., Pepkowitz, S., Goldfinger, D., Ng, H., Irvin, D., Yu, J. S.
(2008). Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients. Cancer Res.
68: 5955-5964
[Abstract][Full Text]
Yin, D., Wang, X., Konda, B. M., Ong, J. M., Hu, J., Sacapano, M. R., Ko, M. K., Espinoza, A. J., Irvin, D. K., Shu, Y., Black, K. L.
(2008). Increase in Brain Tumor Permeability in Glioma-Bearing Rats with Nitric Oxide Donors. Clin. Cancer Res.
14: 4002-4009
[Abstract][Full Text]
Sarkar, D., Park, E. S., Emdad, L., Lee, S.-G., Su, Z.-z., Fisher, P. B.
(2008). Molecular Basis of Nuclear Factor-{kappa}B Activation by Astrocyte Elevated Gene-1. Cancer Res.
68: 1478-1484
[Abstract][Full Text]
Ozduman, K., Wollmann, G., Piepmeier, J. M., van den Pol, A. N.
(2008). Systemic Vesicular Stomatitis Virus Selectively Destroys Multifocal Glioma and Metastatic Carcinoma in Brain. J. Neurosci.
28: 1882-1893
[Abstract][Full Text]
Ziegler, D. S., Kung, A. L., Kieran, M. W.
(2008). Anti-Apoptosis Mechanisms in Malignant Gliomas. JCO
26: 493-500
[Abstract][Full Text]
Hutterer, M., Knyazev, P., Abate, A., Reschke, M., Maier, H., Stefanova, N., Knyazeva, T., Barbieri, V., Reindl, M., Muigg, A., Kostron, H., Stockhammer, G., Ullrich, A.
(2008). Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme. Clin. Cancer Res.
14: 130-138
[Abstract][Full Text]
Jiang, J., Wei, Y., Shen, J., Liu, D., Chen, X., Zhou, J., Zong, H., Yun, X., Kong, X., Zhang, S., Yang, Y., Gu, J.
(2007). Functional Interaction of E1AF and Sp1 in Glioma Invasion. Mol. Cell. Biol.
27: 8770-8782
[Abstract][Full Text]
Fine, H. A., Kim, L., Albert, P. S., Duic, J. P., Ma, H., Zhang, W., Tohnya, T., Figg, W. D., Royce, C.
(2007). A Phase I Trial of Lenalidomide in Patients with Recurrent Primary Central Nervous System Tumors. Clin. Cancer Res.
13: 7101-7106
[Abstract][Full Text]
Rigotti, D.J., Inglese, M., Gonen, O.
(2007). Whole-Brain N-Acetylaspartate as a Surrogate Marker of Neuronal Damage in Diffuse Neurologic Disorders. Am. J. Neuroradiol.
28: 1843-1849
[Abstract][Full Text]
Li, Y., Yin, W., Wang, X., Zhu, W., Huang, Y., Yan, G.
(2007). Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc. Natl. Acad. Sci. USA
104: 13438-13443
[Abstract][Full Text]
Tran, T.-T., Uhl, M., Ma, J. Y., Janssen, L., Sriram, V., Aulwurm, S., Kerr, I., Lam, A., Webb, H. K., Kapoun, A. M., Kizer, D. E., McEnroe, G., Hart, B., Axon, J., Murphy, A., Chakravarty, S., Dugar, S., Protter, A. A., Higgins, L. S., Wick, W., Weller, M., Wong, D. H.
(2007). Inhibiting TGF-{beta} signaling restores immune surveillance in the SMA-560 glioma model. Neuro Oncol
9: 259-270
[Abstract][Full Text]
Coras, R., Holsken, A., Seufert, S., Hauke, J., Eyupoglu, I. Y., Reichel, M., Trankle, C., Siebzehnrubl, F. A., Buslei, R., Blumcke, I., Hahnen, E.
(2007). The peroxisome proliferator-activated receptor-{gamma} agonist troglitazone inhibits transforming growth factor-{beta}-mediated glioma cell migration and brain invasion. Molecular Cancer Therapeutics
6: 1745-1754
[Abstract][Full Text]
Murakami, R., Sugahara, T., Nakamura, H., Hirai, T., Kitajima, M., Hayashida, Y., Baba, Y., Oya, N., Kuratsu, J.-i., Yamashita, Y.
(2007). Malignant Supratentorial Astrocytoma Treated with Postoperative Radiation Therapy: Prognostic Value of Pretreatment Quantitative Diffusion-weighted MR Imaging. Radiology
243: 493-499
[Abstract][Full Text]
Desmurget, M., Bonnetblanc, F., Duffau, H.
(2007). Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain
130: 898-914
[Abstract][Full Text]
Puputti, M., Tynninen, O., Sihto, H., Blom, T., Maenpaa, H., Isola, J., Paetau, A., Joensuu, H., Nupponen, N. N.
(2006). Amplification of KIT, PDGFRA, VEGFR2, and EGFR in Gliomas. Mol Cancer Res
4: 927-934
[Abstract][Full Text]
Inglese, M., Brown, S., Johnson, G., Law, M., Knopp, E., Gonen, O.
(2006). Whole-Brain N-Acetylaspartate Spectroscopy and Diffusion Tensor Imaging in Patients with Newly Diagnosed Gliomas: A Preliminary Study. Am. J. Neuroradiol.
27: 2137-2140
[Abstract][Full Text]
Semmler, A., Simon, M., Moskau, S., Linnebank, M.
(2006). The Methionine Synthase Polymorphism c.2756A>G Alters Susceptibility to Glioblastoma Multiforme.. Cancer Epidemiol. Biomarkers Prev.
15: 2314-2316
[Abstract][Full Text]
Jiang, J., Shen, J., Wu, T., Wei, Y., Chen, X., Zong, H., Zhang, S., Sun, M., Xie, J., Kong, X., Yang, Y., Shen, A., Wang, H., Gu, J.
(2006). Down-regulation of {beta}1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells. Glycobiology
16: 1045-1051
[Abstract][Full Text]
Fomchenko, E. I., Holland, E. C.
(2006). Mouse models of brain tumors and their applications in preclinical trials.. Clin. Cancer Res.
12: 5288-5297
[Abstract][Full Text]
Tabatabai, G., Frank, B., Mohle, R., Weller, M., Wick, W.
(2006). Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-{beta}-dependent HIF-1{alpha}-mediated induction of CXCL12. Brain
129: 2426-2435
[Abstract][Full Text]
Ceyssens, S., Van Laere, K., de Groot, T., Goffin, J., Bormans, G., Mortelmans, L.
(2006). [11C]Methionine PET, Histopathology, and Survival in Primary Brain Tumors and Recurrence. Am. J. Neuroradiol.
27: 1432-1437
[Abstract][Full Text]
McCarter, H., Furlong, W., Whitton, A. C., Feeny, D., DePauw, S., Willan, A. R., Barr, R. D.
(2006). Health Status Measurements at Diagnosis As Predictors of Survival Among Adults With Brain Tumors. JCO
24: 3636-3643
[Abstract][Full Text]
Wallace, D. J., Shen, D., Reed, G. F., Miyanaga, M., Mochizuki, M., Sen, H. N., Dahr, S. S., Buggage, R. R., Nussenblatt, R. B., Chan, C.-C.
(2006). Detection of the bcl-2 t(14;18) Translocation and Proto-Oncogene Expression in Primary Intraocular Lymphoma.. IOVS
47: 2750-2756
[Abstract][Full Text]
Cairncross, G., Berkey, B., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperierre, N., Mehta, M., Curran, W.
(2006). Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. JCO
24: 2707-2714
[Abstract][Full Text]
Finger, P T, Papp, C, Latkany, P, Kurli, M, Iacob, C E
(2006). Anterior chamber paracentesis cytology (cytospin technique) for the diagnosis of intraocular lymphoma. Br. J. Ophthalmol.
90: 690-692
[Abstract][Full Text]
Lee, K. C., Hall, D. E., Hoff, B. A., Moffat, B. A., Sharma, S., Chenevert, T. L., Meyer, C. R., Leopold, W. R., Johnson, T. D., Mazurchuk, R. V., Rehemtulla, A., Ross, B. D.
(2006). Dynamic Imaging of Emerging Resistance during Cancer Therapy.. Cancer Res.
66: 4687-4692
[Abstract][Full Text]
Eyupoglu, I. Y., Hahnen, E., Trankle, C., Savaskan, N. E., Siebzehnrubl, F. A., Buslei, R., Lemke, D., Wick, W., Fahlbusch, R., Blumcke, I.
(2006). Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. Molecular Cancer Therapeutics
5: 1248-1255
[Abstract][Full Text]
Vajkoczy, P., Knyazev, P., Kunkel, A., Capelle, H.-H., Behrndt, S., von Tengg-Kobligk, H., Kiessling, F., Eichelsbacher, U., Essig, M., Read, T.-A., Erber, R., Ullrich, A.
(2006). Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc. Natl. Acad. Sci. USA
103: 5799-5804
[Abstract][Full Text]
Jiang, J., Chen, X., Shen, J., Wei, Y., Wu, T., Yang, Y., Wang, H., Zong, H., Yang, J., Zhang, S., Xie, J., Kong, X., Liu, W., Gu, J.
(2006). beta1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma. J. Biol. Chem.
281: 9482-9489
[Abstract][Full Text]
Wang, L., Wei, Q., Wang, L.-E, Aldape, K. D., Cao, Y., Okcu, M. F., Hess, K. R., El-Zein, R., Gilbert, M. R., Woo, S. Y., Prabhu, S. S., Fuller, G. N., Bondy, M. L.
(2006). Survival Prediction in Patients With Glioblastoma Multiforme by Human Telomerase Genetic Variation. JCO
24: 1627-1632
[Abstract][Full Text]
Tang, Y.M., Ngai, S., Stuckey, S.
(2006). The Solitary Enhancing Cerebral Lesion: Can FLAIR Aid the Differentiation between Glioma and Metastasis?. Am. J. Neuroradiol.
27: 609-611
[Abstract][Full Text]
Lai, R., Chu, R., Fraumeni, M., Thabane, L.
(2006). Quality of Randomized Controlled Trials Reporting in the Primary Treatment of Brain Tumors. JCO
24: 1136-1144
[Abstract][Full Text]
Stupp, R., Hegi, M. E., van den Bent, M. J., Mason, W. P., Weller, M., Mirimanoff, R. O., Cairncross, J. G., on behalf of the European Organisation for Researc,
(2006). Changing paradigms--an update on the multidisciplinary management of malignant glioma.. The Oncologist
11: 165-180
[Abstract][Full Text]
Martin, V., Herrera, F., Carrera-Gonzalez, P., Garcia-Santos, G., Antolin, I., Rodriguez-Blanco, J., Rodriguez, C.
(2006). Intracellular Signaling Pathways Involved in the Cell Growth Inhibition of Glioma Cells by Melatonin. Cancer Res.
66: 1081-1088
[Abstract][Full Text]
Eramo, A., Pallini, R., Lotti, F., Sette, G., Patti, M., Bartucci, M., Ricci-Vitiani, L., Signore, M., Stassi, G., Larocca, L. M., Crino, L., Peschle, C., De Maria, R.
(2005). Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Destruction. Cancer Res.
65: 11469-11477
[Abstract][Full Text]
Lassman, A. B., Rossi, M. R., Razier, J. R., Abrey, L. E., Lieberman, F. S., Grefe, C. N., Lamborn, K., Pao, W., Shih, A. H., Kuhn, J. G., Wilson, R., Nowak, N. J., Cowell, J. K., DeAngelis, L. M., Wen, P., Gilbert, M. R., Chang, S., Yung, W.A., Prados, M., Holland, E. C.
(2005). Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin. Cancer Res.
11: 7841-7850
[Abstract][Full Text]
Cohen, B. A., Knopp, E. A., Rusinek, H., Babb, J. S., Zagzag, D., Gonen, O.
(2005). Assessing Global Invasion of Newly Diagnosed Glial Tumors with Whole-Brain Proton MR Spectroscopy. Am. J. Neuroradiol.
26: 2170-2177
[Abstract][Full Text]
Cloughesy, T. F., Kuhn, J., Robins, H. I., Abrey, L., Wen, P., Fink, K., Lieberman, F. S., Mehta, M., Chang, S., Yung, A., DeAngelis, L., Schiff, D., Junck, L., Groves, M., Paquette, S., Wright, J., Lamborn, K., Sebti, S. M., Prados, M.
(2005). Phase I Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Taking Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study. JCO
23: 6647-6656
[Abstract][Full Text]
Tabatabai, G., Bahr, O., Mohle, R., Eyupoglu, I. Y., Boehmler, A. M., Wischhusen, J., Rieger, J., Blumcke, I., Weller, M., Wick, W.
(2005). Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain
128: 2200-2211
[Abstract][Full Text]
Momota, H., Nerio, E., Holland, E. C.
(2005). Perifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo. Cancer Res.
65: 7429-7435
[Abstract][Full Text]
Grommes, C., Landreth, G. E., Schlegel, U., Heneka, M. T.
(2005). The Nonthiazolidinedione Tyrosine-Based Peroxisome Proliferator-Activated Receptor {gamma} Ligand GW7845 Induces Apoptosis and Limits Migration and Invasion of Rat and Human Glioma Cells. J. Pharmacol. Exp. Ther.
313: 806-813
[Abstract][Full Text]
Moffat, B. A., Chenevert, T. L., Lawrence, T. S., Meyer, C. R., Johnson, T. D., Dong, Q., Tsien, C., Mukherji, S., Quint, D. J., Gebarski, S. S., Robertson, P. L., Junck, L. R., Rehemtulla, A., Ross, B. D.
(2005). Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl. Acad. Sci. USA
102: 5524-5529
[Abstract][Full Text]
Maia, A. C. M. Jr, Malheiros, S. M. F., da Rocha, A. J., da Silva, C. J., Gabbai, A. A., Ferraz, F. A. P., Stavale, J. N.
(2005). MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas. Am. J. Neuroradiol.
26: 777-783
[Abstract][Full Text]
Kim, Y., Hong, H.-H. L., Lachat, Y., Clayton, N. P., Devereux, T. R., Melnick, R. L., Hegi, M. E., Sills, R. C.
(2005). Genetic Alterations in Brain Tumors Following 1,3-Butadiene Exposure in B6C3F1 Mice. Toxicol Pathol
33: 307-312
[Abstract][Full Text]
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J.B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R. C., Ludwin, S. K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J. G., Eisenhauer, E., Mirimanoff, R. O., the European Organisation for Research and Treatme,
(2005). Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. NEJM
352: 987-996
[Abstract][Full Text]
Pauleit, D., Floeth, F., Hamacher, K., Riemenschneider, M. J., Reifenberger, G., Muller, H.-W., Zilles, K., Coenen, H. H., Langen, K.-J.
(2005). O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain
128: 678-687
[Abstract][Full Text]
Neuwelt, E. A., Guastadisegni, P. E., Varallyay, P., Doolittle, N. D.
(2005). Imaging Changes and Cognitive Outcome in Primary CNS Lymphoma after Enhanced Chemotherapy Delivery. Am. J. Neuroradiol.
26: 258-265
[Abstract][Full Text]
Soling, A., Sackewitz, M., Volkmar, M., Schaarschmidt, D., Jacob, R., Holzhausen, H.-J., Rainov, N. G.
(2005). Minichromosome Maintenance Protein 3 Elicits a Cancer-Restricted Immune Response in Patients with Brain Malignancies and Is a Strong Independent Predictor of Survival in Patients with Anaplastic Astrocytoma. Clin. Cancer Res.
11: 249-258
[Abstract][Full Text]
Wheeler, C. J., Das, A., Liu, G., Yu, J. S., Black, K. L.
(2004). Clinical Responsiveness of Glioblastoma Multiforme to Chemotherapy after Vaccination. Clin. Cancer Res.
10: 5316-5326
[Abstract][Full Text]
Houben, M. P. W. A., Louwman, W. J., Tijssen, C. C., Teepen, J. L. J. M., van Duijn, C. M., Coebergh, J. W. W.
(2004). Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann Oncol
15: 1256-1260
[Abstract][Full Text]
Pueschel, J. K.
(2004). Integrative Tumor Board: Glioblastoma Multiforme: Neurooncology. Integr Cancer Ther
3: 151-152
Ostermann, S., Csajka, C., Buclin, T., Leyvraz, S., Lejeune, F., Decosterd, L. A., Stupp, R.
(2004). Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients. Clin. Cancer Res.
10: 3728-3736
[Abstract][Full Text]
Lebrun, C., Fontaine, D., Ramaioli, A., Vandenbos, F., Chanalet, S., Lonjon, M., Michiels, J. F., Bourg, V., Paquis, P., Chatel, M., Frenay, M., The Nice Brain Tumor Study Group,
(2004). Long-term outcome of oligodendrogliomas. Neurology
62: 1783-1787
[Abstract][Full Text]
Okcu, M. F., Selvan, M., Wang, L.-E, Stout, L., Erana, R., Airewele, G., Adatto, P., Hess, K., Ali-Osman, F., Groves, M., Yung, A. W. K., Levin, V. A., Wei, Q., Bondy, M.
(2004). Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma. Clin. Cancer Res.
10: 2618-2625
[Abstract][Full Text]
Xie, D., Yin, D., Tong, X., O'Kelly, J., Mori, A., Miller, C., Black, K., Gui, D., Said, J. W., Koeffler, H. P.
(2004). Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and {beta}-Catenin-TCF/Lef Signaling Pathways. Cancer Res.
64: 1987-1996
[Abstract][Full Text]
Xie, D., Yin, D., Wang, H.-J., Liu, G.-T., Elashoff, R., Black, K., Koeffler, H. P.
(2004). Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas. Clin. Cancer Res.
10: 2072-2081
[Abstract][Full Text]
Benes, L, Kappus, C, McGregor, G P, Bertalanffy, H, Mennel, H D, Hagner, S
(2004). The immunohistochemical expression of calcitonin receptor-like receptor (CRLR) in human gliomas. J. Clin. Pathol.
57: 172-176
[Abstract][Full Text]
Asgharian, B., Chen, Y.-J., Patronas, N. J., Peghini, P. L., Reynolds, J. C., Vortmeyer, A., Zhuang, Z., Venzon, D. J., Gibril, F., Jensen, R. T.
(2004). Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1. Clin. Cancer Res.
10: 869-880
[Abstract][Full Text]
Schwartz, S. A., Weil, R. J., Johnson, M. D., Toms, S. A., Caprioli, R. M.
(2004). Protein Profiling in Brain Tumors Using Mass Spectrometry: Feasibility of a New Technique for the Analysis of Protein Expression. Clin. Cancer Res.
10: 981-987
[Abstract][Full Text]
Benjamin, R. K., Hochberg, F. H., Fox, E., Bungay, P. M., Elmquist, W. F., Stewart, C. F., Gallo, J. M., Collins, J. M., Pelletier, R. P., de Groot, J. F., Hickner, R. C., Cavus, I., Grossman, S. A., Colvin, O. M.
(2004). Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium. Neuro Oncol
6: 65-74
[Abstract]
Vos, M. J., Hoekstra, O. S., Barkhof, F., Berkhof, J., Heimans, J. J., van Groeningen, C. J., Vandertop, W. P., Slotman, B. J., Postma, T. J.
(2003). Thallium-201 Single-Photon Emission Computed Tomography As an Early Predictor of Outcome in Recurrent Glioma. JCO
21: 3559-3565
[Abstract][Full Text]
Shingu, T., Yamada, K., Hara, N., Moritake, K., Osago, H., Terashima, M., Uemura, T., Yamasaki, T., Tsuchiya, M.
(2003). Synergistic Augmentation of Antimicrotubule Agent-induced Cytotoxicity by a Phosphoinositide 3-Kinase Inhibitor in Human Malignant Glioma Cells. Cancer Res.
63: 4044-4047
[Abstract][Full Text]
Falchetti, M. L., Pierconti, F., Casalbore, P., Maggiano, N., Levi, A., Larocca, L. M., Pallini, R.
(2003). Glioblastoma Induces Vascular Endothelial Cells to Express Telomerase in Vitro. Cancer Res.
63: 3750-3754
[Abstract][Full Text]
Weiss, W. A., Burns, M. J., Hackett, C., Aldape, K., Hill, J. R., Kuriyama, H., Kuriyama, N., Milshteyn, N., Roberts, T., Wendland, M. F., DePinho, R., Israel, M. A.
(2003). Genetic Determinants of Malignancy in a Mouse Model for Oligodendroglioma. Cancer Res.
63: 1589-1595
[Abstract][Full Text]
Jensen, N. A., Pedersen, K. M., Lihme, F., Rask, L., Nielsen, J. V., Rasmussen, T. E., Mitchelmore, C.
(2003). Astroglial c-Myc Overexpression Predisposes Mice to Primary Malignant Gliomas. J. Biol. Chem.
278: 8300-8308
[Abstract][Full Text]
Goldhaber, S. Z., Dunn, K., Gerhard-Herman, M., Park, J. K., Black, P. M.
(2002). Low Rate of Venous Thromboembolism After Craniotomy for Brain Tumor Using Multimodality Prophylaxis. Chest
122: 1933-1937
[Abstract][Full Text]
Roelcke, U., Hausmann, O., Merlo, A., Missimer, J., Maguire, R. P., Freitag, P., Radu, E. W., Weinreich, R., Gratzl, O., Leenders, K. L.
(2002). PET Imaging Drug Distribution After Intratumoral Injection: The Case for 124I-Iododeoxyuridine in Malignant Gliomas. JNM
43: 1444-1451
[Abstract][Full Text]
Landman, R. E., Horwith, M., Peterson, R. E., Khandji, A. G., Wardlaw, S. L.
(2002). Long-Term Survival with ACTH-Secreting Carcinoma of the Pituitary: A Case Report and Review of the Literature. J. Clin. Endocrinol. Metab.
87: 3084-3089
[Abstract][Full Text]
Ouafik, L'H., Sauze, S., Boudouresque, F., Chinot, O., Delfino, C., Fina, F., Vuaroqueaux, V., Dussert, C., Palmari, J., Dufour, H., Grisoli, F., Casellas, P., Brunner, N., Martin, P.-M.
(2002). Neutralization of Adrenomedullin Inhibits the Growth of Human Glioblastoma Cell Lines in Vitro and Suppresses Tumor Xenograft Growth in Vivo. Am. J. Pathol.
160: 1279-1292
[Abstract][Full Text]
Stupp, R., Dietrich, P.-Y., Kraljevic, S. O., Pica, A., Maillard, I., Maeder, P., Meuli, R., Janzer, R., Pizzolato, G., Miralbell, R., Porchet, F., Regli, L., de Tribolet, N., Mirimanoff, R. O., Leyvraz, S.
(2002). Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide. JCO
20: 1375-1382
[Abstract][Full Text]
da Rocha, A. B., Mans, D.R.A., Regner, A., Schwartsmann, G.
(2002). Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas?. The Oncologist
7: 17-33
[Abstract][Full Text]
Martinez di Montemuros, F., Tavazzi, D., Salsano, E., Piepoli, T., Pollo, B., Fiorelli, G., Finocchiaro, G.
(2001). High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas. Neurology
57: 1342-1342
[Full Text]
Lu, Q. R., Park, J. K., Noll, E., Chan, J. A., Alberta, J., Yuk, D., Alzamora, M. G., Louis, D. N., Stiles, C. D., Rowitch, D. H., Black, P. M.
(2001). Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc. Natl. Acad. Sci. USA
10.1073/pnas.181340798v1
[Abstract][Full Text]
Lubin, E., Sullivan, P. R., DeAngelis, L. M.
(2001). Brain Tumors. NEJM
344: 1478-1479
[Full Text]
Hoey, J.
(2001). No link between cellular-phone use and brain tumours?. CMAJ
164: 537-537
[Full Text]
Lu, Q. R., Park, J. K., Noll, E., Chan, J. A., Alberta, J., Yuk, D., Alzamora, M. G., Louis, D. N., Stiles, C. D., Rowitch, D. H., Black, P. M.
(2001). Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc. Natl. Acad. Sci. USA
98: 10851-10856
[Abstract][Full Text]
Previous
